FDA NDC Directory · JSON-LD · Markdown

OXBRYTA

NDC 72786-111 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Generic nameVoxelotor
Labeler / ManufacturerGlobal Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216157
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsVOXELOTOR (300 mg/1)
Marketing started20211217
Package count2

External sources

Source: openFDA. Public-domain (CC0).